Human lipocalin-1 (Lcn-1, also called Tear Lipocalin), a member of the lipocalin structural superfamily, is produced by a number of glands and tissues and is known to bind an unusual large array of hydrophobic ligands. Apart from its specific function in stabilizing the lipid film of human tear fluid, it is suggested to act as a physiological scavenger of potentially harmful lipophilic compounds, in general. In order to characterize proteins involved in the reception, detoxification or degradation of these ligands, a cDNA phage-display library from human pituitary gland was constructed and screened for proteins interacting with Lcn-1. Using this method a Lcn-1 interacting phage was isolated which expressed a novel human protein. 
INTRODUCTION
The protein superfamily of lipocalins consists of small mainly secretory proteins defined on the basis of conserved amino acid sequence motifs and their common structure. Functionally they share several properties including the ability to bind/transport a remarkable array of small hydrophobic molecules, the formation of macromolecular complexes and the binding to specific cell surface receptors (1) (2) (3) .
Whereas a large number of various lipophilic ligands able to bind to lipocalins are known, only limited data are available concerning the identity of lipocalin receptors.
There is clear evidence of a specific receptor for plasma retinol-binding protein (RBP) (4) (5) (6) (7) , and more indirect evidence for receptors for alpha 1-microglobulin (A1M) (8) , major urinary protein (MUP) (9) , ß-lactoglobulin (Blg) (10) , olfactory binding protein (OBP) (11) , alpha 1-acid glycoprotein (AGP) (12) and glycodelin (13) , but with exception of megalin, which seems to be an endocytic receptor for a variety of soluble macromolecules including several lipocalins, no specific lipocalin receptor has been fully characterized, so far (14). This lack of knowledge is a major disadvantage in understanding the biological function of many lipocalin members.
We have identified Lcn-1 (identical with Tear lipocalin or von Ebner´s gland protein) as a human member of the lipocalin superfamily (15) . It is produced by a number of secretory glands and tissues, including lacrimal and lingual salivary glands, prostate, mucosal glands of the tracheobronchial tree, nasal mucosa, sweat glands and by some neuroendocrine tissues (15) (16) (17) (18) (19) (20) (21) . Lcn-1 is an unusual member of 4 its main function seems to be scavenging of lipophilic, potentially harmful molecules, thus acting as a protection factor for cells and tissues (25) . However, the mechanism of clearence or detoxification of the putative harmful ligands is unknown.
In the present study we have used a phage-display based technique for interaction screening of a complex cDNA expression library with Lcn-1 as bait to isolate proteins that may be involved in the reception or degradation of Lcn-1 specific ligands. Here we describe the identification, molecular cloning, expression and subcellular localization of a novel Lcn-1 interacting membrane protein. Our findings set the stage for exploring the molecular mechanism of the lipocalin-receptor interaction in more detail. Moreover, this is the first successful attempt of identifying a lipocalin receptor using phage-display techniques. 
EXPERIMENTAL PROCEDURES
General Methods -Total RNA was extracted by RNazol TM B (Cinna/Biotecx, USA) which is based on the method developed by Chomczynski and Sacchi (26) . For
Western blot analysis proteins were transferred to nitrocellulose membranes (Sartorius, BRD) and alkaline phosphatase conjugated IgG was used as secondary antibody (Sigma, USA). Detection was performed using the ECL system (Amersham, UK).
Construction of the cDNA Phage-display Library -Poly A + RNA was prepared using Dynabeads Oligo (dT) 25 (Dynal, Norway) exactly as described by the supplier.
A portion of pituitary gland mRNA was reverse transcribed using adapter primer ph.D (5´-AATAGGGTACC(T)17 -3´) and Superscript II reverse transcriptase (Gibco BRL, Great Britain), according to the manufacturer´s specifications. After second strand synthesis using RNaseH and E.coli DNA-polymerase I (Roche, Germany), a portion of the cDNA was digested with KpnI, subjected to agarose gel electrophoresis and the region between 200 and 3000 base pairs was eluted. Phagemid pJuFo, a generous gift from R. Crameri (27) were used. For a binding assay in solution, the 6xHis tagged N-terminal fragment of LIMR (10-20 mg) bound to Ni-NTA resin (50-100 ml) was incubated with 2 mg of purified Lcn-1 in 1 ml of 50mM NaH 2 PO 4 /300 mM NaCl (pH 8.0) at 4°C for 2h. The resin was then washed twice with 50mM NaH 2 PO 4 /300 mM NaCl (pH 8.0) buffer containing 1% Triton X-100, and the His-tagged LIMR and any associated proteins were eluted with 250 mM imidazole. 20 ml of each eluate was subjected to SDS-PAGE and immunoblotting using a Lcn-1 specific antiserum.
Membrane preparation -NT2 cell membranes were prepared after homogenization in 10 mM Tris/HCl (pH 7.0), 0.1 mM PMSF, 0.1 mM benzamidine and 1mM iodacetamide essentially as described (28) . 
RESULTS

Isolation of Lcn-1 Binding Proteins from the Phage-display Library -Lcn-1 was
found to be expressed in a variety of human glands or tissues. Among them we found pituitary gland to be an excellent source of intact mRNA. Therefore mRNA isolated from this gland was used for constructing a phagemid cDNA library. As cloning vector we used pJuFo (27) , a gene pIII fusion based phagemid system, since it is known that relatively large fusion moieties can be added onto pIII without Therefore we focused our research on one of the eleven identical clones (pJuFo.33), which encode the uncharacterized human protein. Therefore, in a next step we isolated the LIMR encoding cDNA by RT-PCR using mRNA isolated from human pituitary gland. As shown in Fig. 1 Hydropathy analysis of the deduced amino acid sequence using TMbase (30), revealed nine putative transmembrane helices (Fig. 3 So far, Lcn-1 was found to be produced by the serous glands of several tissues exclusively. However, in search for a cell line which produces Lcn-1 we have recently detected production of this protein by human teratocarcinoma NT2 cells. Therefore,
Isolation of the Entire LIMR cDNA by RT-PCR and Determination of the Genomic
Structure of the LIMR gene -
we have investigated the expression of LIMR by these cells using RT-PCR analysis.
From Fig. 6B it is evident that NT-2 cells express both, Lcn-1 and LIMR. Thus, the NT2 cells were choosen as a reliable object for further characterization of the cellular distribution of LIMR.
Western Blot Analysis of NT2 Cell Membrane Fractions -Membranes of NT2 cells
were prepared by subcellular fractionation and the proteins contained within the different fractions were analyzed by Western blotting using the LIMR specific antiserum. As a marker for the plasma membrane fraction an antiserum against the typical membrane located zeta subunit of the NMDA receptor was used. As seen in (Fig. 8A) . To demonstrate the specifity of staining, the LIMR antibodies in the antiserum were blocked/saturated with 20µg/ml recombinant LIMR peptide at 37°C for 1h. In this case the cell staining was almost completely abolished ( receptor, but rather a membrane-associated protein involved in enzymatic processing of retinol (36, 37) . Since no other specific RBP receptor has been identified so far, there is still no consensus whether retinol transfer into the cell is receptor driven or proceeds via passive diffusion (7, 38) . There is also convincing evidence that in some cells RBP undergoes internalization by a receptor mediated endocytotic process (39).
Another well characterized protein which is supposed to interact with lipocalins, is megalin. This protein, also called gp330 is an epithelial endocytic receptor, with a single transmembrane region, and shares some characteristic features with the low density lipoprotein receptor family (40, 41) . From studies on a megalin knock-out mouse it was concluded to interact with different lipocalins, including RBP, MUP, OBP and A1M (42) . However, since it also binds a variety of other macromolecular ligands, such as thyroglobulin, apolipoproteinA, clusterin, albumin and insulin, its specific role in lipocalin binding remains unclear.
With exception of these two defined molecules the interaction of other lipocalins with putative receptors is only marginally characterized and a number of interactions described are likely to be of no physiological relevance. However, also those receptors that have been characterized in some detail, show no consensus in biochemical or biophysical properties, suggesting a great diversity of receptor structure (14).
There is also no consensus in the mechanism of interaction between lipocalins and their receptors. In principle, lipocalin receptors have been found in both groups, 
